IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia

Hypertens Pregnancy. 2015;34(3):291-306. doi: 10.3109/10641955.2015.1032054. Epub 2015 May 21.

Abstract

Objective: The reduced uterine perfusion pressure (RUPP) rat model of preeclampsia was used to determine the effects of added interleukin-10 (IL-10) on Tregs and hypertension in response to placental ischemia and how the decrease in these anti-inflammatory factors mediates the pathophysiology of preeclampsia.

Methods: IL-10 (2.5 ng/kg/d) was infused via osmotic mini-pump implanted intraperitoneally on day 14 of gestation and, at the same time, the RUPP procedure was performed.

Results: IL-10 reduced mean arterial pressure (p < 0.001), decreased CD4(+) T cells (p = 0.044), while increasing Tregs (p = 0.043) which led to lower IL-6 and TNF-α (p = 0.008 and p = 0.003), reduced AT1-AA production (p < 0.001), and decreased oxidative stress (p = 0.029) in RUPP rats.

Conclusion: These data indicate that IL-10 supplementation increases Tregs and helps to balance the altered immune system seen during preeclampsia.

Keywords: Hypertension; inflammation; pregnancy..

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Disease Models, Animal
  • Female
  • Hypertension / blood
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Interleukin-10 / pharmacology*
  • Interleukin-10 / therapeutic use
  • Interleukin-6 / blood
  • Ischemia / drug therapy
  • Ischemia / metabolism
  • Placenta / blood supply
  • Placenta / metabolism
  • Pre-Eclampsia / blood
  • Pre-Eclampsia / drug therapy*
  • Pre-Eclampsia / physiopathology
  • Pregnancy
  • Rats, Sprague-Dawley
  • T-Lymphocytes, Regulatory / drug effects*
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Interleukin-10